| AFB | Acid-fast bacilli |
| AMK | Amikacin |
| ATT | Anti-tuberculosis therapy |
| AZM | Azithromycin |
| CLR | Clarithromycin |
| CMV | Cytomegalovirus |
| CFX | Cefoxitin |
| CTB | Cutaneous tuberculosis |
| EMB | Ethambutol |
| HRZE | Isoniazid + rifampicin + pyrazinamide + ethambutol |
| IGRA | Interferon-γ release assay |
| INH | Isoniazid |
| Lfx | Levofloxacin |
| MAC | Mycobacterium avium complex |
| mNGS | Metagenomic next-generation sequencing |
| MTB | Mycobacterium tuberculosis |
| NTM | Nontuberculous mycobacteria |
| NR | Not reported |
| PZA | Pyrazinamide |
| RIF | Rifampicin |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.